Zelnorm Cardiovascular Side Effects & Heart Attack - Zelnorm FDA Warning

resource4thepeople.com — On March 30, 2007, the Swiss Pharmaceutical company Novartis announced that it was suspending all marketing and sales of the drug Zelnorm® due to a request by the Food and Drug Administration. First approved in 2002, Zelnorm® (tegaserod maleate) is a treatment for irritable bowel syndrome (IBS), an illness that can cause debilitating abdominal...